Improving quality of care in endoscopy of inflammatory bowel disease: can we do better?


Journal

Expert review of gastroenterology & hepatology
ISSN: 1747-4132
Titre abrégé: Expert Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101278199

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 17 6 2020
medline: 29 7 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Endoscopy plays a key role in the management of inflammatory bowel disease (IBD). There is an increased need for quality assurance programs that evaluate the quality, safety and patient experiences of endoscopy, by assessing procedural and clinical outcomes. This review aims to summarize the most important quality indicators of endoscopy in IBD patients and could serve as the basis to improve quality endoscopic procedures and patients' perception of endoscopy in the future. However, further studies and consensus reports are necessary to standardize the quality of care in the endoscopy unit of all IBD centers. Developing an understanding of the patient-reported perception is important for both clinicians and patients, as it facilitates patient engagement with their care. Moreover, implementing education in reporting is crucial f and the use of verifiable databases, generated from electronic reporting systems, should be encouraged rather than unverified self-reporting, to have greater validity for documenting and to formally evaluate endoscopic practice data with audits. The use of artificial intelligence may improve the quality of endoscopy, by increasing the adenoma detection rate and helping endoscopists in the challenging differentiation between inflammatory and neoplastic lesions.

Identifiants

pubmed: 32543983
doi: 10.1080/17474124.2020.1780913
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-828

Auteurs

Alessandra Zilli (A)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.

Antonio Capogreco (A)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.

Federica Furfaro (F)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.

Mariangela Allocca (M)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.
Department of Biomedical Sciences, Humanitas University , Milan, Italy.

Giulia Roda (G)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.

Laura Loy (L)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.

Gionata Fiorino (G)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.
Department of Biomedical Sciences, Humanitas University , Milan, Italy.

Silvio Danese (S)

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute , Milan, Italy.
Department of Biomedical Sciences, Humanitas University , Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH